ϰϲͼ

header-logo
Overdose Fatality Review Program
Overdose Fatality Review
Overdose Fatality Review Program

Wisconsin Overdose Fatality Review

A locally based, multi-disciplinary process for understanding the risk factors and circumstances leading to fatal overdoses and identifying opportunities to prevent future overdoses. The basis of OFR – like all fatality reviews – is that overdose fatalities could have been prevented with the right action, timing, intervention, and/or response.

Overdose deaths are preventable. Through fatality reviews, key community partners are able to look into each death and identify prevention initiatives that may save another life.

Jessica Blahnik, Marathon County Medical Examiner

Overdose Fatality Review Teams

Teams

OFR teams are county-based. Twenty-two teams covering 24 counties utilize OFR in their efforts to prevent fatal overdoses.

Learn about our teams
Overdose Fatality Review Data

Data

Information gathered about fatal overdoses drives prevention and intervention efforts at the local and state levels.

Learn about our data

OFR State Advisory Group

The mission of the OFR State Advisory Group is to reduce overdose fatalities in Wisconsin through support of the overdose fatality review process and recommendations of the local multi-disciplinary teams.

The OFR State Advisory Group is a multi-disciplinary group which seeks to:

• Promote OFR as a tool for local communities to address the overdose epidemic
• Receive, evaluate, and implement state-level recommendations from local OFR teams
• Address data sharing barriers in understanding the circumstances leading to fatal overdoses

Learn about the Overdose Fatality Review State Advisory Group (PDF)

The OFR State Advisory Group convenes quarterly and meetings are open to the public. The next meeting is Thursday, January 9, 2025.

Learn about the Meeting of the Overdose Fatality Review State Advisory Group (PDF)

Upcoming Events & Webinars

There are no upcoming webinars at this time.

Webinar Archive

all
December 2020

Connecting individuals who are incarcerated to treatment after return to the community: Successes and areas for growth in Wisconsin

December 9, 2020

  • Alisha Kraus
  • Michael Meulemans
Download PowerPoint presentation (PDF)

November 2020

Wisconsin Prescription Drug Monitoring Program: Trends in controlled substance prescribing

November 17, 2020

Panelist:

  • Marjorie Liu

Download PowerPoint presentation (PDF)

October 2020

Treatment of Substance Use Disorder: Principles of Drug Addiction Treatment and Implications in Wisconsin

October 13, 2020

Panelist:

  • Dr. Michael Miller

Download PowerPoint presentation (PDF)

September 2020

Mitigating Overdose Risk through Harm Reduction: Vivent Health Adaptations During COVID-19

September 29, 2020

Panelists:

  • Kristen Grimes
  • Ritchie Martin
  • Logan Self

Download PowerPoint presentation (PDF)

August 2020

Substance Use Disorder and COVID-19: Challenges and resiliency among treatment providers and individuals working toward recovery

August 18, 2020

Panelists:

  • Faith Gladem
  • Ryan Gorman
  • Amy Molinski
  • Patrick Reilly

OFR Program Collaborators

ϰϲͼ, Institute for Health & Equity, Division of Epidemiology

Constance Kostelac, PhD
ckostelac@mcw.edu
(414) 955-8670
Assistant Professor

 

Jessica Ohlrich, MPA
johlrich@mcw.edu
(414) 955-4124
Research Program Coordinator II

Amy Parry, MPH
aparry@mcw.edu
(414) 955-4120
Program Manager

 

Wisconsin Department of Justice, Bureau of Justice Information and Analysis

Starr Moss
MossSH@doj.state.wi.us
(608) 261-8108
Senior Research Analyst

Wisconsin Department of Health Services, Division of Public Health, Bureau of Community Health Promotion, Behavioral Health Section

Raina Haralampopoulos
mraina.haralampopoulos@dhs.wisconsin.gov
(608) 267-3783
Opioid Harm Prevention Coordinator

This material development was funded in part by the Cooperative Agreement 1 NU17CE010219-01-00 Centers for Disease Control and Prevention (CDC). Its contents do not necessarily represent the official views of the CDC or the U.S. Department of Health and Human Services. In addition, this project was supported by Grant No. 2019-AR-BX-K051 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice's Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.